Mangoceuticals board and preferred shareholder approve new Series D preferred stock

🌐 Investing.com (Cyprus) —
Mangoceuticals board and preferred shareholder approve new Series D preferred stock

AI Summary

Mangoceuticals' board and a preferred shareholder approved the creation of new Series D preferred stock. The report does not provide details about the issuance terms or its financial purpose.

Markets Deals Health Mangoceuticals preferred stock Series D shareholder approval corporate governance

Read original source →